|
US4229447A
(en)
|
1979-06-04 |
1980-10-21 |
American Home Products Corporation |
Intraoral methods of using benzodiazepines
|
|
IE56702B1
(en)
*
|
1982-12-01 |
1991-11-06 |
Usv Pharma Corp |
Antiinflammatory antiallergic compounds
|
|
US4596795A
(en)
|
1984-04-25 |
1986-06-24 |
The United States Of America As Represented By The Secretary, Dept. Of Health & Human Services |
Administration of sex hormones in the form of hydrophilic cyclodextrin derivatives
|
|
US4755386A
(en)
|
1986-01-22 |
1988-07-05 |
Schering Corporation |
Buccal formulation
|
|
US5021456A
(en)
|
1988-02-25 |
1991-06-04 |
Merrell Dow Pharmaceuticals Inc. |
Inhibitors of lysyl oxidase
|
|
US5739136A
(en)
|
1989-10-17 |
1998-04-14 |
Ellinwood, Jr.; Everett H. |
Intraoral dosing method of administering medicaments
|
|
US5563143A
(en)
|
1994-09-21 |
1996-10-08 |
Pfizer Inc. |
Catechol diether compounds as inhibitors of TNF release
|
|
US6956047B1
(en)
|
1995-06-06 |
2005-10-18 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
|
US7067664B1
(en)
|
1995-06-06 |
2006-06-27 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
|
US6632823B1
(en)
|
1997-12-22 |
2003-10-14 |
Merck & Co., Inc. |
Substituted pyridine compounds useful as modulators of acetylcholine receptors
|
|
MXPA02007047A
(es)
|
2000-01-18 |
2002-12-13 |
Pfizer Prod Inc |
Antagonista del factor liberador de corticotropina.
|
|
US6878714B2
(en)
|
2001-01-12 |
2005-04-12 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
US7102009B2
(en)
|
2001-01-12 |
2006-09-05 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
|
US6995162B2
(en)
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
|
US7105682B2
(en)
|
2001-01-12 |
2006-09-12 |
Amgen Inc. |
Substituted amine derivatives and methods of use
|
|
US20030134836A1
(en)
|
2001-01-12 |
2003-07-17 |
Amgen Inc. |
Substituted arylamine derivatives and methods of use
|
|
US20020147198A1
(en)
|
2001-01-12 |
2002-10-10 |
Guoqing Chen |
Substituted arylamine derivatives and methods of use
|
|
US7307088B2
(en)
|
2002-07-09 |
2007-12-11 |
Amgen Inc. |
Substituted anthranilic amide derivatives and methods of use
|
|
FI20030030A0
(fi)
|
2003-01-09 |
2003-01-09 |
Orion Corp |
Uusia yhdisteitä
|
|
CN1787817B
(zh)
|
2003-05-19 |
2011-09-07 |
Irm责任有限公司 |
免疫抑制剂化合物及组合物
|
|
WO2005082370A1
(en)
|
2004-01-29 |
2005-09-09 |
Pfizer Products Inc. |
Combinations of an atypical antipsychotic and an aminomethylpyridyloxymethyl/benzisoxazole azabicyclic derivatives for treating cns disorders
|
|
CA2558568A1
(en)
|
2004-03-12 |
2005-09-29 |
Eli Lilly And Company |
Opioid receptor antagonists
|
|
WO2005092836A1
(en)
|
2004-03-15 |
2005-10-06 |
Eli Lilly And Company |
Opioid receptor antagonists
|
|
CN1976907A
(zh)
|
2004-04-30 |
2007-06-06 |
武田药品工业株式会社 |
杂环酰胺化合物及其作为mmp－13抑制剂的用途
|
|
US7507748B2
(en)
|
2004-07-22 |
2009-03-24 |
Amgen Inc. |
Substituted aryl-amine derivatives and methods of use
|
|
JP2008512441A
(ja)
|
2004-09-10 |
2008-04-24 |
ファイザー・プロダクツ・インク |
ピリジルオキシメチル、及びベンズイソオキサゾール・アザビシクロ誘導体を使用する、認知障害の治療方法
|
|
BRPI0515143A
(pt)
|
2004-09-10 |
2008-07-08 |
Pfizer Prod Inc |
usos de derivados azabicìclicos de piridiloximetila e benzisoxazol para a preparação de uma composição farmacêutica para o tratamento dos distúrbios de humor
|
|
WO2006052546A2
(en)
|
2004-11-04 |
2006-05-18 |
Neurogen Corporation |
Pyrazolylmethyl heteroaryl derivatives
|
|
DE102004056226A1
(de)
|
2004-11-22 |
2006-05-24 |
Burchardt, Elmar Reinhold, Dr.Dr. |
Neuartige Inhibitoren der Lysyloxidase
|
|
US7759493B2
(en)
|
2005-01-31 |
2010-07-20 |
Merck Sharp & Dohme Corp. |
Antidiabetic bicyclic compounds
|
|
AR055041A1
(es)
|
2005-03-23 |
2007-08-01 |
Merck Frosst Canada Ltd |
Tiadiazoles y oxadiazoles como inhibidores de la sintesis de leucotrienos. composiciones farmaceuticas.
|
|
CA2618586A1
(en)
|
2005-08-11 |
2007-02-15 |
Merck Frosst Canada Ltd. |
Novel substituted 1,2,3-triazolylmethyl-benzothiophene or -indole and their use as leukotriene biosynthesis inhibitors
|
|
US7405302B2
(en)
|
2005-10-11 |
2008-07-29 |
Amira Pharmaceuticals, Inc. |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
ITMI20051943A1
(it)
*
|
2005-10-14 |
2007-04-15 |
Procos Spa |
Processo di risoluzione anantiomerica di 2-aminometil-pirrolidine 1-sostitute per ammidazione in presenza di lipasi
|
|
US7977359B2
(en)
|
2005-11-04 |
2011-07-12 |
Amira Pharmaceuticals, Inc. |
5-lipdxygenase-activating protein (FLAP) inhibitors
|
|
US20070225285A1
(en)
|
2005-11-04 |
2007-09-27 |
Amira Pharmaceuticals, Inc. |
5-lipoxygenase-activating protein (flap) inhibitors
|
|
US20070219206A1
(en)
|
2005-11-04 |
2007-09-20 |
Amira Pharmaceuticals, Inc. |
5-lipoxygenase-activating protein (flap) inhibitors
|
|
WO2007087250A2
(en)
|
2006-01-23 |
2007-08-02 |
Amira Pharmaceuticals, Inc. |
Tricyclic inhibitors of 5-lipoxygenase
|
|
GB0614579D0
(en)
|
2006-07-21 |
2006-08-30 |
Black James Foundation |
Pyrimidine derivatives
|
|
EP2121703A4
(en)
|
2006-08-18 |
2011-12-28 |
Astrazeneca Ab |
THIENOPYRIMIDIN-4-ON- AND THIENOPYRIDAZIN-7-ONDERIVATES AS MCH-RL ANTAGONISTS
|
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
|
ES2700141T3
(es)
|
2007-08-02 |
2019-02-14 |
Gilead Biologics Inc |
Anticuerpos inhibidores LOXL2 y usos de los mismos
|
|
KR20130031233A
(ko)
|
2009-07-28 |
2013-03-28 |
아나코르 파마슈티칼스 인코포레이티드 |
삼치환된 붕소 함유 분자
|
|
EP2467162A4
(en)
|
2009-08-21 |
2013-10-02 |
Gilead Biologics Inc |
THERAPEUTIC PROCESSES AND RELATED COMPOSITIONS
|
|
US8680246B2
(en)
|
2010-02-04 |
2014-03-25 |
Gilead Biologics, Inc. |
Antibodies that bind to lysyl oxidase-like 2 (LOXL2)
|
|
US8513230B2
(en)
|
2010-03-05 |
2013-08-20 |
Karyopharm Therapeutics, Inc. |
Nuclear transport modulators and uses thereof
|
|
CA2818542A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為ｊａｋ抑制劑之環己基氮雜環丁烷衍生物
|
|
RU2014120166A
(ru)
|
2011-10-20 |
2015-11-27 |
ГЛЭКСОСМИТКЛАЙН ЭлЭлСи |
Замещенные бициклические аза-гетероциклы и их аналоги в качестве модуляторов сиртуина
|
|
BR112014026399B1
(pt)
|
2012-04-25 |
2022-11-01 |
Raqualia Pharma Inc |
Composto de fórmula (ii), composição farmacêutica, uso e processo para preparar uma composição farmacêutica
|
|
JP2016500700A
(ja)
|
2012-10-30 |
2016-01-14 |
ギリアード サイエンシーズ， インコーポレイテッド |
リシルオキシダーゼ様２（ｌｏｘｌ２）に関する治療および診断方法
|
|
CN104854086B
(zh)
|
2012-12-18 |
2017-06-27 |
Ea制药株式会社 |
杂环酰胺衍生物和含有其的药物
|
|
JP2018522812A
(ja)
|
2014-08-05 |
2018-08-16 |
ザ ユニヴァーシティ オブ ブリティッシュ コロンビア |
カスパーゼ−６のモジュレーター
|
|
US9051320B1
(en)
|
2014-08-18 |
2015-06-09 |
Pharmakea, Inc. |
Methods for the treatment of metabolic disorders by a selective small molecule autotaxin inhibitor
|
|
WO2016128529A1
(en)
|
2015-02-15 |
2016-08-18 |
F. Hoffmann-La Roche Ag |
1-(het)arylsulfonyl-(pyrrolidine or piperidine)-2-carboxamide derivatives and their use as trpa1 antagonists
|
|
WO2016144702A1
(en)
|
2015-03-06 |
2016-09-15 |
Pharmakea, Inc. |
Lysyl oxidase-like 2 inhibitors and uses thereof
|
|
WO2016144703A1
(en)
|
2015-03-06 |
2016-09-15 |
Pharmakea, Inc. |
Fluorinated lysyl oxidase-like 2 inhibitors and uses thereof
|
|
MX390964B
(es)
|
2016-09-07 |
2025-03-21 |
Pharmakea Inc |
Formas cristalinas de un inhibidor tipo lisil oxidasa 2 y metodos de realizacion.
|
|
MX2019002612A
(es)
|
2016-09-07 |
2019-08-21 |
Pharmakea Inc |
Usos de un inhibidor de lisil-oxidasa tipo 2.
|